We use cookies to deliver our online services. Details of the cookies we use and instructions on how to disable them are set out in our Cookies Policy. By using this website you agree to our use of cookies. To close this message click close.

CMS finally announces interim reimbursement rates for some molecular diagnostic tests but pricing uncertainty remains

11 June 2013

Health Alert

CMS published a long-awaited list of interim prices for new molecular diagnostic codes. This list is a key step in the process of changing the way molecular diagnostics are reimbursed.

Read more: CMS finally announces interim reimbursement rates for some molecular diagnostic tests but pricing uncertainty remains

The team

Loading data